Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and <sup>131</sup>I resistance of thyroid carcinoma cells through PI3K/Akt activation

Chen,Wanzhi; Yu,Jichun; Xie,Rong; Zhou,Tao; Xiong,Chengfeng; Zhang,Shuyong; Zhong,Meijun

doi:10.3892/or.2021.7954

Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and ¹³¹I resistance of thyroid carcinoma cells through PI3K/Akt activation

Authors:
- Wanzhi Chen
- Jichun Yu
- Rong Xie
- Tao Zhou
- Chengfeng Xiong
- Shuyong Zhang
- Meijun Zhong
View Affiliations

Affiliations: Department of Thyroid Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: January 27, 2021 https://doi.org/10.3892/or.2021.7954
Article Number: 3
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radioactive iodine (RAI, ¹³¹I) therapy is the main treatment for thyroid carcinoma (TC). Long noncoding RNA (lncRNA)/microRNA (miR) competing endogenous RNA (ceRNA) networks have aroused great interest for their roles in gene expression. The present study aimed to investigate the effect of lncRNA SNHG7 on the growth and ¹³¹I resistance of TC. Differentially expressed lncRNAs in TC and paracancerous tissues were analyzed. The binding of miR‑9‑5p with small nucleolar RNA host gene 7 (SNHG7) and dipeptidyl‑peptidase 4 (DPP4) was identified. Gain‑ and loss‑of‑function analyses of SNHG7 and miR‑9‑5p were performed to determine their effects on the growth and ¹³¹I resistance of TC cells. The activity of the PI3K/Akt pathway was evaluated. Consequently, upregulated SNHG7 was revealed in TC tissues and correlated with ¹³¹I resistance. Silencing of SNHG7 or overexpressing miR‑9‑5p inhibited the growth and ¹³¹I resistance of TC cells. SNHG7 acted as a ceRNA of miR‑9‑5p to enhance DPP4 expression. Overexpressed SNHG7 increased DPP4 expression and activated the PI3K/Akt signaling pathway by sponging miR‑9‑5p. The in vitro results were reproduced in vivo. In summary, the present study provided evidence that the SNHG7/miR‑9‑5p/DPP4 ceRNA network could promote the growth and ¹³¹I resistance of TC cells via PI3K/Akt activation. The present study may offer novel options for TC treatment.

View Figures

View References

1	Ding C, Yu H, Shi C, Shi T, Qin H and Cui Y: MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in thyroid cancer. Biomed Pharmacother. 110:528–536. 2019. View Article : Google Scholar : PubMed/NCBI
2	Li H, Zhao L, Zhang Z, Zhang H, Ding C and Su Z: Roles of microRNA let-7b in thyroid cancer by regulating HMGA2. Tumour Biol. 39:10104283177192742017. View Article : Google Scholar : PubMed/NCBI
3	Huang Y, Yu S, Cao S, Yin Y, Hong S, Guan H, Li Y and Xiao H: MicroRNA-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit b alpha expression. Thyroid. 28:1162–1173. 2018. View Article : Google Scholar : PubMed/NCBI
4	Gezer E, Selek A, Tarkun I, Canturk Z and Çetinarslan B: Papillary thyroid cancer presenting as a primary renal tumor with multiple pulmonary and bone metastases: A case report. J Med Case Rep. 13:952019. View Article : Google Scholar : PubMed/NCBI
5	Liu C, Feng Z, Chen T, Lv J, Liu P, Jia L, Zhu J, Chen F, Yang C and Deng Z: Downregulation of NEAT1 reverses the radioactive iodine resistance of thyroid cancer cell via miR-101-3p/FN1/PI3K-AKT signaling pathway. Cell Cycle. 18:167–203. 2019. View Article : Google Scholar : PubMed/NCBI
6	Xiang C, Zhang ML, Zhao QZ, Xie QP, Yan HC, Yu X, Wang P and Wang Y: lncRNA-SLC6A9-5:2: A potent sensitizer in ¹³¹I-resistant thyroid cancer with PARP-1 induction. Oncotarget. 8:22954–22967. 2017. View Article : Google Scholar : PubMed/NCBI
7	Wan ZY, Song F, Sun Z, Chen YF, Zhang WL, Samartzis D, Ma CJ, Che L, Liu X, Ali MA, et al: Aberrantly expressed long noncoding RNAs in human intervertebral disc degeneration: A microarray related study. Arthritis Res Ther. 16:4652014. View Article : Google Scholar : PubMed/NCBI
8	Chen Y, Shen Z, Zhi Y, Zhou H, Zhang K, Wang T, Feng B, Chen Y, Song H, Wang R and Chu X: Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression. Arch Biochem Biophys. 645:117–125. 2018. View Article : Google Scholar : PubMed/NCBI
9	Gao YT and Zhou YC: Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381. Eur Rev Med Pharmacol Sci. 23:6588–6595. 2019.PubMed/NCBI
10	Yao X, Liu C, Liu C, Xi W, Sun S and Gao Z: lncRNA SNHG7 sponges miR-425 to promote proliferation, migration, and invasion of hepatic carcinoma cells via Wnt/β-catenin/EMT signalling pathway. Cell Biochem Funct. 37:525–533. 2019. View Article : Google Scholar : PubMed/NCBI
11	Wang J, Wang B, Ren H and Chen W: miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun. 509:241–248. 2019. View Article : Google Scholar : PubMed/NCBI
12	Shi D, Wang H, Ding M, Yang M, Li C, Yang W and Chen L: MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in thyroid cancer. Onco Targets Ther. 12:6605–6616. 2019. View Article : Google Scholar : PubMed/NCBI
13	Guo F, Hou X and Sun Q: MicroRNA-9-5p functions as a tumor suppressor in papillary thyroid cancer via targeting BRAF. Oncol Lett. 16:6815–6821. 2018.PubMed/NCBI
14	Chen Z, Liu Z, Shen L and Jiang H: Long non-coding RNA SNHG7 promotes the fracture repair through negative modulation of miR-9. Am J Transl Res. 11:974–982. 2019.PubMed/NCBI
15	Wang Y, Han J, Lv Y and Zhang G: miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4. Onco Targets Ther. 12:4225–4233. 2019. View Article : Google Scholar : PubMed/NCBI
16	Li C, Zhou Y, Cai Y, Shui C, Liu W, Wang X, Jiang J, Zeng D, Gui C and Sun R: Parthenolide inhibits the proliferation of MDA-T32 thyroid cancer cells in vitro and in mouse tumor xenografts and activates autophagy and apoptosis by downregulation of the mammalian target of rapamycin (mTOR)/PI3K/AKT Signaling Pathway. Med Sci Monit. 25:5054–5061. 2019. View Article : Google Scholar : PubMed/NCBI
17	Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009. View Article : Google Scholar : PubMed/NCBI
18	Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI
19	Chandrashekar DS, Bashel B, Balasubramanya SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Chehrehasa F, Meedeniya AC, Dwyer P, Abrahamsen G and Mackay-Sim A: EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J Neurosci Methods. 177:122–130. 2009. View Article : Google Scholar : PubMed/NCBI
22	Mas-Ponte D, Carlevaro-Fita J, Palumbo E, Hermoso Pulido T, Guigo R and Johnson R: LncATLAS database for subcellular localization of long noncoding RNAs. RNA. 23:1080–1087. 2017. View Article : Google Scholar : PubMed/NCBI
23	Agarwal V, Bell GW, Nam JW and Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. Elife. 4:e050052015. View Article : Google Scholar
24	Zatroch KK, Knight CG, Reimer JN and Pang DS: Refinement of intraperitoneal injection of sodium pentobarbital for euthanasia in laboratory rats (Rattus Norvegicus). BMC Vet Res. 13:602017. View Article : Google Scholar : PubMed/NCBI
25	Deng Y, Zhao F, Zhang Z, Sun F and Wang M: Long noncoding RNA SNHG7 promotes the tumor growth and epithelial-to-mesenchymal transition via regulation of miR-34a signals in osteosarcoma. Cancer Biother Radiopharm. 33:365–372. 2018. View Article : Google Scholar : PubMed/NCBI
26	Shan Y, Ma J, Pan Y, Hu J, Liu B and Jia L: lncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. 9:7222018. View Article : Google Scholar : PubMed/NCBI
27	Li Y, Zhao L, Li N, Miao Y, Zhou H and Jia L: miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1. Oncol Rep. 37:2193–2200. 2017. View Article : Google Scholar : PubMed/NCBI
28	Li Q, Chang Y, Mu L and Song Y: MicroRNA-9 enhances chemotherapy sensitivity of glioma to TMZ by suppressing TOPO II via the NF-κB signaling pathway. Oncol Lett. 17:4819–4826. 2019.PubMed/NCBI
29	Amit M, Na'ara S, Francis D, Matanis W, Zolotov S, Eisenhaber B, Eisenhaber F, Weiler Sagie M, Malkin L, Billan S, et al: Post-translational regulation of radioactive iodine therapy response in thyroid cancer. J Natl Cancer Inst. Dec 1–2017.(Epub ahead of print). doi: 10.1093/jnci/djx092. View Article : Google Scholar : PubMed/NCBI
30	Hu X, Ding D, Zhang J and Cui J: Knockdown of lncRNA HOTAIR sensitizes breast cancer cells to ionizing radiation through activating miR-218. Biosci Rep. 39:BSR201810382019. View Article : Google Scholar : PubMed/NCBI
31	Wang L, Xu T, Cui X, Han M, Zhou LH, Wei ZX, Xu ZJ and Jiang Y: Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1. Eur Rev Med Pharmacol Sci. 23:6186–6193. 2019.PubMed/NCBI
32	Sun BZ, Ji DG, Feng ZX and Wang Y: Long noncoding RNA SNHG7 represses the expression of RBM5 to strengthen metastasis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 23:5699–5704. 2019.PubMed/NCBI
33	Wang YH, Huo BL, Li C, Ma G and Cao W: Knockdown of long noncoding RNA SNHG7 inhibits the proliferation and promotes apoptosis of thyroid cancer cells by downregulating BDNF. Eur Rev Med Pharmacol Sci. 23:4815–4821. 2019.PubMed/NCBI
34	Chen K, Abuduwufuer A, Zhang H, Luo L, Suotesiyali M and Zou Y: SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 23:6935–6943. 2019.PubMed/NCBI
35	Wu P, Tang Y, Fang X, Xie C, Zeng J, Wang W and Zhao S: Metformin suppresses hypopharyngeal cancer growth by epigenetically silencing long Non-coding RNA SNHG7 in FaDu Cells. Front Pharmacol. 10:1432019. View Article : Google Scholar : PubMed/NCBI
36	Fan Y, Shi Y, Lin Z, Huang X, Li J, Huang W, Shen D, Zhuang G and Liu W: miR-9-5p suppresses malignant biological behaviors of human gastric cancer cells by negative regulation of TNFAIP8L3. Dig Dis Sci. 64:2823–2829. 2019. View Article : Google Scholar : PubMed/NCBI
37	Xie CH, Cao YM, Huang Y, Shi QW, Guo JH, Fan ZW, Li JG, Chen BW and Wu BY: Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression. Tumour Biol. 37:15031–15041. 2016. View Article : Google Scholar : PubMed/NCBI
38	Wei W, Dong Z, Gao H, Zhang YY, Shao LH, Jin LL, Lv YH, Zhao G, Shen YN and Jin SZ: MicroRNA-9 enhanced radiosensitivity and its mechanism of DNA methylation in non-small cell lung cancer. Gene. 710:178–185. 2019. View Article : Google Scholar : PubMed/NCBI
39	Javidroozi M, Zucker S and Chen WT: Plasma seprase and DPP4 levels as markers of disease and prognosis in cancer. Dis Markers. 32:309–320. 2012. View Article : Google Scholar : PubMed/NCBI
40	Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol. 11:892018. View Article : Google Scholar : PubMed/NCBI
41	Yi J and Gao ZF: MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4. Int J Biol Macromol. 130:1–9. 2019. View Article : Google Scholar : PubMed/NCBI
42	Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ, Kim JH, Yin J, Yoo H, Lee SH and Park JB: Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One. 7:e474492012. View Article : Google Scholar : PubMed/NCBI